Retension Pharmaceuticals, Inc. RTSN
13.01 USD -0.88 (-6.34%)
Regular-session close
12.99 -0.02 -0.15%
After hours · Nov 19, 4:00 PM ET
12.61 Day range 13.92
9.66 52-week range 18.64
- YTD
- +23.55%
- 1 year
- +23.55%
5D +1.88 (+15.65%)
- Market cap
- 108.39M
- EPS (ttm)
- -2.61
- YTD return
- +23.55%
- 1-year return
- +23.55%
- Volume
- 54.57K
- Avg volume
- 147.43K
- Open
- 13.92
- Previous close
- 13.89
- Day's range
- 12.61 – 13.92
- 52-week range
- 9.66 – 18.64
Fundamental scorecard
5 of 25 checks passed on RTSN’s reported financials
5of 25 checks passed
- Value 0 of 5
- Growth 0 of 5
- Profitability 0 of 5
- Financial health 5 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
RTSN Revenue — quarterly 0
RTSN Net income — quarterly -5.92M
RTSN EPS — quarterly -7.33
News
Retension Pharmaceuticals Q3 EPS $(7.33) Misses $(0.75) Estimate
Retension Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Corporate Update Oppenheimer Initiates Coverage On Retension Pharmaceuticals with Outperform Rating, Announces Price Target of $50
Guggenheim Initiates Coverage On Retension Pharmaceuticals with Buy Rating, Announces Price Target of $55
Your note
Sign in to keep a note on RTSN — it syncs with the Stock Master app.
